98 related articles for article (PubMed ID: 25471501)
1. [Role of SALL4 in regulating multi-drug resistance of small cell lung cancer and its clinical significance].
Liu H; Bai Y; Wang W; Guo L
Zhonghua Bing Li Xue Za Zhi; 2014 Sep; 43(9):604-8. PubMed ID: 25471501
[TBL] [Abstract][Full Text] [Related]
2. [Role and clinical significance of RLIP76 in regulation of multi-drug resistance of small cell lung cancer].
Haixia P; Yifeng B; Honglin H
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):266-71. PubMed ID: 26462890
[TBL] [Abstract][Full Text] [Related]
3. [Influence of interference of WIG-1 on the multi-drug resistance in small cell lung cancer].
Luo S; Bai Y; Lan H
Zhonghua Zhong Liu Za Zhi; 2014 Oct; 36(10):733-8. PubMed ID: 25567302
[TBL] [Abstract][Full Text] [Related]
4. [Role of SPHK1 regulates multi-drug resistance of small cell lung cancer
and its clinical significance].
Yang L; Hu H; Deng Y; Bai Y
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):769-77. PubMed ID: 25404266
[TBL] [Abstract][Full Text] [Related]
5. [Role of homeobox gene A5 in multidrug resistance of human small cell lung cancer cells].
Xiao F; Chen Z; Zeng X; Bai Y; Guo L; Li Y
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1665-8. PubMed ID: 24273274
[TBL] [Abstract][Full Text] [Related]
6. [Role of TGF-β1 in multi-drug resistance in small cell lung cancer and its clinical significance].
Liu H; Wang W; Zhang G; Guo L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):419-425. PubMed ID: 28490700
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
9. Identification of DJ-1 as a contributor to multidrug resistance in human small-cell lung cancer using proteomic analysis.
Gao H; Niu Y; Li M; Fang S; Guo L
Int J Exp Pathol; 2017 Apr; 98(2):67-74. PubMed ID: 28580701
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
[TBL] [Abstract][Full Text] [Related]
12. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
Guo L; Zhou Y; Sun Y; Zhang F
Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
[TBL] [Abstract][Full Text] [Related]
13. [Up-regulation of DLL1 may promote the chemotherapeutic sensitivity in small cell lung cancer].
Liu H; Peng J; Bai Y; Guo L
Zhongguo Fei Ai Za Zhi; 2013 Jun; 16(6):282-8. PubMed ID: 23769341
[TBL] [Abstract][Full Text] [Related]
14. MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer.
Lai J; Yang H; Zhu Y; Ruan M; Huang Y; Zhang Q
BMC Cancer; 2019 Jun; 19(1):602. PubMed ID: 31215481
[TBL] [Abstract][Full Text] [Related]
15. FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1.
Chen R; Li D; Zheng M; Chen B; Wei T; Wang Y; Li M; Huang W; Tong Q; Wang Q; Zhu Y; Fang W; Guo L; Fang S
J Cell Mol Med; 2020 Feb; 24(3):2123-2134. PubMed ID: 31957179
[TBL] [Abstract][Full Text] [Related]
16. Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer.
Fang S; Zeng X; Zhu W; Tang R; Chao Y; Guo L
Exp Mol Pathol; 2014 Jun; 96(3):438-44. PubMed ID: 24769353
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin and Vinorelbine -Mediated Electrochemotherapeutic Approach Against Multidrug Resistant Small Cell Lung Cancer (H69AR)
Drąg-Zalesińska M; Saczko J; Choromańska A; Szewczyk A; Rembiałkowska N; Kulbacka J; Rzechonek A
Anticancer Res; 2019 Jul; 39(7):3711-3718. PubMed ID: 31262897
[TBL] [Abstract][Full Text] [Related]
18. In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability.
Santos AO; Pereira JP; Pedroso de Lima MC; Simões S; Moreira JN
Braz J Med Biol Res; 2010 Oct; 43(10):1001-9. PubMed ID: 20922271
[TBL] [Abstract][Full Text] [Related]
19. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
Giaccone G; van Ark-Otte J; Rubio GJ; Gazdar AF; Broxterman HJ; Dingemans AM; Flens MJ; Scheper RJ; Pinedo HM
Int J Cancer; 1996 Jun; 66(6):760-7. PubMed ID: 8647646
[TBL] [Abstract][Full Text] [Related]
20. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
